Earnings Feed
Start Free
Home/Filings/4/0001444380-25-000006
4//SEC Filing

DEMANE MICHAEL F 4

Accession 0001444380-25-000006

CIK 0001444380other
View on SEC.govCompany Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:53 PM ET

Size

7.5 KB

Accession

0001444380-25-000006

Insider Transaction Report

Form 4
Period: 2024-12-31
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2024-12-31+7,056→ 61,863 total
Holdings

  • Common Stock

    (indirect: See footnote)
    219,145

  • Common Stock

    (indirect: See footnote)
    164,344

  • Common Stock

    (indirect: See footnote)
    58,266
Footnotes (5)
  • [F1]Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
  • [F2]Includes 19,169 restricted stock units.
  • [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
  • [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
  • [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.

Documents

1 file

Issuer

NEVRO CORP

CIK 0001444380

→
Entity typeother

Related Parties

1
  • filerCIK 0001174533

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:53 PM ET
Size
7.5 KB
View on SEC.gov